The present study demonstrated, for the first time, that the genetic variants in the RAC1 gene represent novel susceptibility markers for diabetic retinopathy, nephropathy, angiopathy of the lower extremities, and neuropathy, with the potential to influence the risk of diabetic complications through perturbations in redox homeostasis. This evidence concerns the gene RAC1 and kidney disorder.